Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesHepatoprotective effect of TNF-alpha blockade in psoriatic arthritis: A cross-sectional study
Annals of Rheumatic Diseases, 11/09/09
Seitz M et al. – The results of this study suggest a protective effect of TNF &alpha inhibitors against the development of liver fibrosis in patients with PsA.
Methods- Consecutive patients with RA and PsA who had undergone MTX treatment for at least 1 y +/- TNF blockade for over 6 mos
- Liver fibrosis assessed using non-invasive transient elastography (FibroScan)
- Regression models used to compare FibroScan values of RA and PsA patients receiving TNF &alpha blockers with those who were not
- FibroScan assessments performed on 51 RA and 43 PsA patients
- Compared to RA patients, those with PsA predominantly young males, received lower cumulative dosages of MTX and exhibited higher incidence of liver steatosis and hyperlipidemia
- Abnormal result observed in 7.1% of anti-TNF-naïve and 13% of anti-TNF-treated patients in RA group, and in 30% of anti-TNF-naïve and 4.3% of anti-TNF-treated patients in PsA group (OR = 0.11, 95% CI 0.02 to 0.98)
- Results of PsA group were robust when adjusted for baseline characteristics
Michael Seitz, 11/10/09
| This study provides first preliminary hint that TNF-blockade might be prevent liver fibrosis in patients with psoriatic arthritis undergoing longterm methotrexate treatment and exhibiting enhanced co-morbidity such as liver steatosis, dyslipidemia, diabetes mellitus that might predisose patients to enhanced hepatotoxicity |
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Genotype at the sIL-6R A358C polymorphism does not influence response to anti-TNF therapy in patients with rheumatoid arthritis
Rheumatology, 11/22/09
Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis
Journal of Rheumatology, 11/20/09
Connective tissue growth factor promotes articular damage by increased osteoclastogenesis in patients with rheumatoid arthritis
Arthritis Research & Therapy, 11/20/09
Today in Other Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Update in treatment options for psoriatic arthritis
Expert Review of Clinical Immunology, 11/20/09
Pain in arthritis
European Journal of Pain, 11/17/09
SAPHO syndrome: is a range of pathogen-associated rheumatic diseases extended
Arthritis Research & Therapy, 11/17/09
Sponsor
Article Search
Sponsor